Skip to main content
. 2022 Jun 30;13:921997. doi: 10.3389/fendo.2022.921997

Table 1.

Characteristics of study population by hypertension or pre hypertension.

All subjects No hypertension subjects
Hypertension No hypertension Pvalue Prehypertension Ideal BP Pvalue
N 11621 23111 13164 9947
Age, years 61 (55,68) 56 (51,61) <0.001 57 (53,63) 54 (49,59) <0.001
Sex, (%) <0.001 <0.001
Male 4059 (34.9) 6435 (27.8) 4099 (31.1) 2336 (23.5)
Female 7562 (65.1) 16676 (72.2) 9065 (68.9) 7611 (76.5)
CVAI 122.76 (98.49,147.00) 95.46 (71.28,120.92) <0.001 104.35 (81.22,129.07) 83.39 (60.72,107.46) <0.001
VAI 2.05 (1.32,3.24) 1.74 (1.12,2.77) <0.001 1.88 (1.20,2.97) 1.57 (1.04,2.48) <0.001
BMI, Kg/m2 25.5 (23.4,27.8) 23.7 (21.7,25.9) <0.001 24.3 (22.3,26.6) 22.9 (21.0,25.0) <0.001
WC 90 (83,96) 84 (78,90) <0.001 86 (92,80) 81 (75,88) <0.001
WHR 0.91 (0.86,0.95) 0.88 (0.83,0.92) <0.001 0.89 (0.84,0.93) 0.86 (0.82,0.91) <0.001
WHtR 0.56 (0.52,0.60) 0.52 (0.49,0.56) <0.001 0.54 (0.50,0.57) 0.51 (0.47,0.55) <0.001
LDL-C, mmol/L 3.06 (2.46,3.67) 2.88 (2.32,3.48) <0.001 2.94 (2.39,3.55) 2.79 (2.23,3.38) <0.001
HDL-C, mmol/L 1.27 (1.08,1.49) 1.30 (1.09,1.53) <0.001 1.28 (1.09,1.51) 1.32 (1.11,1.57) <0.001
TC, mmol/L 5.21 (4.47,5.94) 4.97 (4.26,5.70) <0.001 5.06 (4.33,5.79) 4.85 (4.17,5.58) <0.001
TG, mmol/L 1.51 (1.08,2.17) 1.30 (0.94,1.87) <0.001 1.38 (1.00,2.00) 1.20 (0.88,1.70) <0.001
HbA1c, % 6.0 (5.7,6.4) 5.8 (5.6,6.2) <0.001 5.9 (5.6,6.2) 5.8 (5.5,6.1) <0.001
ALT, U/L 16 (12,23) 14 (11,20) <0.001 15 (11,21) 14 (10,19) <0.001
AST, U/L 21 (18,26) 20 (17,24) <0.001 20 (17,25) 20 (16,24) <0.001
GGT, U/L 23 (17,36) 19 (14,29) <0.001 21 (15,31) 18 (13,27) <0.001
eGFR, mL/ (min·1.73 m2) 87.94 (77.51,99.15) 90.71 (81.42,101.32) <0.001 90.22 (80.93,100.74) 91.53 (82.09,102.05) <0.001
Drinking, (%) 0.001 0.001
Never 8821 (75.9) 17297 (74.8) 9840 (74.7) 7457 (75.0)
Occasional 1788 (15.4) 4544 (19.7) 2874 (18.8) 2070 (20.8)
Frequently 1012 (8.7) 1270 (5.5) 850 (6.5) 420 (4.2)
Smoking, (%) 0.038 0.026
Never 10052 (86.5) 19783 (85.6) 11218 (85.2) 8565 (86.1)
Occasional 241 (2.1) 537 (2.3) 296 (2.2) 241 (2.4)
Frequently 1328 (11.4) 2791 (12.1) 1650 (12.5) 1141 (11.5)
Diabetes, (%) <0.001 <0.001
Yes 1712 (14.7) 1892 (8.2) 1294 (9.8) 598 (6.0)
No 9909 (85.3) 21219 (91.8) 11870 (90.2) 9349 (94.0)
Physical activity, (%) <0.001 0.028
Low 9685 (83.3) 18150 (78.6) 10464 (79.4) 7689 (77.3)
Moderate 1369 (11.8) 3512 (15.2) 1903 (14.5) 1609 (16.2)
High 567 (4.9) 1449 (6.3) 791 (6.1) 652 (6.6)
Married/cohabitating, (%) <0.001 0.153
Yes 10061 (86.6) 20630 (89.3) 11753 (89.3) 8877 (89.3)
No 1560 (13.4) 2481 (10.7) 1411 (10.7) 1070 (10.7)
CVD, (%) <0.001 <0.001
Yes 892 (7.68) 857 (3.71) 602 (4.57) 255 (2.56)
No 10729 (92.32) 22254 (96.29) 12562 (95.43) 9692 (97.44)

Data were mean ± SD or median (IQR) for skewed variables or numbers (proportions) for categorical variables.

CVAI chinese visceral adiposity index, VAI visceral adiposity index, BMI body mass index, WC waist circumference, WHtR waist to height ratio, WHR waist-to-hip ratio, HbA1c glycosylated hemoglobin, ALT alanine transferase, AST aspartate transferase, GGT gamma-glutamyl transferase, TG triglyceride, TC Total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, CVD cardiovascular disease.